Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer ConferencePRNewsWire • Wednesday
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research SymposiumPRNewsWire • 09/03/24
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferencePRNewsWire • 08/26/24
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual MeetingPRNewsWire • 07/29/24
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T TherapyPRNewsWire • 07/23/24
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical TrialPRNewsWire • 06/24/24
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical TrialPRNewsWire • 05/21/24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesPRNewsWire • 05/08/24
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaPRNewsWire • 05/06/24
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024PRNewsWire • 04/30/24
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory BoardPRNewsWire • 04/18/24
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesPRNewsWire • 03/14/24
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical TrialPRNewsWire • 02/12/24
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology ConferencePRNewsWire • 01/29/24
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine TechnologyPRNewsWire • 01/23/24
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024PRNewsWire • 01/10/24
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer VaccinePRNewsWire • 12/06/23
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer VaccinePRNewsWire • 12/06/23
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine TechnologyPRNewsWire • 11/27/23